In addition, we showed that knockdown of SMYD2 abolished the in vivo phosphorylation of tyrosine 1278/1282/1283 as well as tyrosine 1604 in the two NSCLC cell lines that have an oncogenic EML4‐ALK fused gene. The gene discussed is ALK; the disease is non-small cell lung carcinoma.